Ovarian Cancer
Research from Nextcea, Inc. provides new data about ovarian cancer
Published in Healthcare Finance, Tax and Law Weekly, October 31st, 2007
Investigators publish new data in the report 'Drug safety evaluation through biomarker analysis--a toxicity study in the cynomolgus monkey using an antibody-cytotoxic conjugate against ovarian cancer.' According to a study from the United States, "'Antibody-cytotoxin conjugates are complex novel therapeutic agents whose toxicological properties are not presently well understood. The objective of this study was to identify serum biomarkers that correlate with MLN8866 (an Antibody-Cytotoxic Conjugate, mAb8866-CT) pathological events in monkeys and to predict the maximal tolerated dose (MTD) level using biomarkers."
"Cynomolgus monkeys were administered a single dose...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
More Articles from Healthcare Finance, Tax and Law Weekly
- AAA Michigan
Michigan Senate Committee Votes in Favor of 'Opt-Out' Option for State's Helmet Law; AAA Says Deaths and Injuries Will Increase - Acute Myeloid Leukemia Therapy
Investigators at Methodist Hospital, Department of Medicine target acute myeloid leukemia therapy - Addiction Medicine
Study data from A. Kariminia and colleagues update understanding of addiction medicine - Alcoholism Therapy
Research from Yale University, Department of Internal Medicine yields new data on alcoholism therapy - Aspect Medical Systems, Inc.
Aspect Medical Systems, Inc. Reports Effectiveness of Shelf Registration Statement - AssistNow
AssistNow Offers Area Employers Complimentary Needs Assessment in Recognition of National Drug-Free Work Week - More from this issue of Healthcare Finance, Tax and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
